Glycomimetics Stock Performance
| GLYC Stock | USD 0.23 0.01 2.87% |
GlycoMimetics holds a performance score of 6 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.41, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning GlycoMimetics are expected to decrease by larger amounts. On the other hand, during market turmoil, GlycoMimetics is expected to outperform it. Use GlycoMimetics potential upside and the relationship between the skewness and price action indicator , to analyze future returns on GlycoMimetics.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in GlycoMimetics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, GlycoMimetics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Capital One Initiates Coverage of GlycoMimetics with Overweight Recommendation - MSN | 09/24/2024 |
2 | SERD Market is Predicted to Exhibit Remarkable Growth Owing to the Usage of Faslodex in Combination, Strong Performance of ORSERDU, and Speedy Progress of Other... | 10/02/2024 |
3 | Acquisition by Chinmaya Rath of 250000 shares of GlycoMimetics at 3.11 subject to Rule 16b-3 | 10/11/2024 |
4 | GlycoMimetics Announces National Cancer Institute Phase 23 Study of Uproleselan Did Not Meet Primary Endpoint | 10/29/2024 |
5 | GlycoMimetics Sees Unusually Large Options Volume | 10/31/2024 |
6 | GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting | 11/06/2024 |
7 | GlycoMimetics Earns Sell Rating from Analysts at StockNews.com | 12/11/2024 |
| Begin Period Cash Flow | 47.9 M |
GlycoMimetics |
GlycoMimetics Relative Risk vs. Return Landscape
If you would invest 16.00 in GlycoMimetics on September 18, 2024 and sell it today you would earn a total of 8.00 from holding GlycoMimetics or generate 50.0% return on investment over 90 days. GlycoMimetics is currently generating 2.1086% in daily expected returns and assumes 24.4633% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than GlycoMimetics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
GlycoMimetics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GlycoMimetics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GlycoMimetics, and traders can use it to determine the average amount a GlycoMimetics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0862
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | GLYC | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 24.46 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.11 actual daily | 42 58% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average GlycoMimetics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlycoMimetics by adding it to a well-diversified portfolio.
GlycoMimetics Fundamentals Growth
GlycoMimetics Stock prices reflect investors' perceptions of the future prospects and financial health of GlycoMimetics, and GlycoMimetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GlycoMimetics Stock performance.
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.59 | ||||
| Current Valuation | 1.27 M | ||||
| Shares Outstanding | 64.48 M | ||||
| Price To Earning | (7.99) X | ||||
| Price To Book | 1.35 X | ||||
| Price To Sales | 1,547 X | ||||
| Revenue | 10 K | ||||
| Gross Profit | 75 K | ||||
| EBITDA | (39.12 M) | ||||
| Net Income | (36.9 M) | ||||
| Cash And Equivalents | 60.24 M | ||||
| Cash Per Share | 1.15 X | ||||
| Total Debt | 808.4 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 6.85 X | ||||
| Book Value Per Share | 0.60 X | ||||
| Cash Flow From Operations | (34.88 M) | ||||
| Earnings Per Share | (0.62) X | ||||
| Market Capitalization | 15.47 M | ||||
| Total Asset | 45.32 M | ||||
| Retained Earnings | (456.49 M) | ||||
| Working Capital | 36.96 M | ||||
| Current Asset | 46.52 M | ||||
| Current Liabilities | 5.42 M | ||||
About GlycoMimetics Performance
By analyzing GlycoMimetics' fundamental ratios, stakeholders can gain valuable insights into GlycoMimetics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GlycoMimetics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GlycoMimetics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (45.96) | (48.25) | |
| Return On Tangible Assets | (0.81) | (0.85) | |
| Return On Capital Employed | (1.02) | (1.07) | |
| Return On Assets | (0.81) | (0.85) | |
| Return On Equity | (0.96) | (1.01) |
Things to note about GlycoMimetics performance evaluation
Checking the ongoing alerts about GlycoMimetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GlycoMimetics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GlycoMimetics is way too risky over 90 days horizon | |
| GlycoMimetics has some characteristics of a very speculative penny stock | |
| GlycoMimetics appears to be risky and price may revert if volatility continues | |
| GlycoMimetics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 10 K. Net Loss for the year was (36.9 M) with profit before overhead, payroll, taxes, and interest of 75 K. | |
| GlycoMimetics currently holds about 60.24 M in cash with (34.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: GlycoMimetics Earns Sell Rating from Analysts at StockNews.com |
- Analyzing GlycoMimetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GlycoMimetics' stock is overvalued or undervalued compared to its peers.
- Examining GlycoMimetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GlycoMimetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GlycoMimetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GlycoMimetics' stock. These opinions can provide insight into GlycoMimetics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GlycoMimetics Stock analysis
When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |